This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Kidney and Renal Pelvic Cancer
  • /
  • Cabozantinib: an Active Novel Multikinase Inhibito...

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.

Read time: 1 mins
Published:28th Feb 2017
Author: Tannir NM, Schwab G, Grünwald V.
Availability: Free full text
Ref.:Tannir NM, Schwab G, Gr´┐Żnwald V.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest